-
Epileptic Disorders : International... Sep 2006There is currently increasing interest in identifying and classifying pediatric benign epilepsy syndromes and recently several new syndromes have been recognized. Benign... (Review)
Review
There is currently increasing interest in identifying and classifying pediatric benign epilepsy syndromes and recently several new syndromes have been recognized. Benign epilepsy syndromes, by definition, occur in children with normal developmental history, respond well to therapy, and remit without sequelae. The large majority of children with benign epilepsy syndromes follow a truly benign course. The concept of benign epilepsy syndromes has, however, been challenged by the minority of patients who continue to have seizures despite therapy, develop new seizures after initial remission, or exhibit neuropsychological abnormalities. Without long-term follow-up, benignity can not be truly ascertained a priori. Thus it may be preferable to use the terms possible and probable before the name of a specific syndrome until such time that the diagnosis of a definite benign syndrome is confirmed on long-term follow-up. In this review of the pediatric benign localization-related epilepsy syndromes, we address the concept of benignity and the process of diagnosis of a benign epilepsy syndrome. In addition we review the epidemiology, clinical manifestations, EEG findings, work-up, diagnostic criteria, differential diagnosis, genetics, management and prognosis of benign infantile familial convulsions, benign partial epilepsy in infancy with complex partial seizures, benign partial epilepsy in infancy with secondarily generalized seizures, benign infantile convulsions associated with mild gastroenteritis, and benign infantile focal epilepsy with midline spikes and waves during sleep.
Topics: Child, Preschool; Diagnosis, Differential; Electroencephalography; Epilepsy, Benign Neonatal; Humans; Infant; Infant, Newborn
PubMed: 16987737
DOI: No ID Found -
La Revue Du Praticien Apr 2018
Topics: Humans; Male; Prostatic Hyperplasia
PubMed: 30869403
DOI: No ID Found -
Journal of Clinical Neurophysiology :... Jul 1991Although rolandic epilepsy is the only epileptic syndrome that, at present, fully meets all the criteria of benignity and is widely recognized as such, there are also... (Review)
Review
Although rolandic epilepsy is the only epileptic syndrome that, at present, fully meets all the criteria of benignity and is widely recognized as such, there are also other forms of partial epilepsy that are benign. These are also genetically determined and age-dependent, occurring in neurologically intact children older than 18 months of age. As a rule, the seizures are brief and infrequent, usually responding well to antiepileptic drugs and remitting spontaneously before adulthood. The EEG background is normal, the morphology of the spikes is typical, and they are activated by sleep; generalized spike-wave discharges may occur. During the past decade, there have been reports of a number of additional syndromes of benign partial epilepsy. These include benign occipital epilepsy (the most common in this group), benign frontal epilepsy, benign epilepsy with affective symptomatology (or benign psychomotor epilepsy), benign epilepsy with extreme somatosensory evoked potentials, benign partial epilepsy of adolescence, and benign epilepsy associated with multiple spike foci. The Landau-Kleffner syndrome is often included among the benign epilepsies. These nonrolandic benign epilepsies are described in detail, and the relevant literature is reviewed.
Topics: Adolescent; Child; Child, Preschool; Electroencephalography; Epilepsies, Partial; Female; Humans; Infant; Male; Prognosis
PubMed: 1918333
DOI: 10.1097/00004691-199107010-00004 -
Progres En Urologie : Journal de... Feb 2016The medicoeconomic issues of drug management of benign prostatic hyperplasia (BPH) are essential due to the aging population and the increasing number of therapeutic... (Review)
Review
INTRODUCTION
The medicoeconomic issues of drug management of benign prostatic hyperplasia (BPH) are essential due to the aging population and the increasing number of therapeutic options. It is thus essential to assess the cost-effectiveness in order to define the most appropriate therapeutic strategies economically. The objective of this work was to conduct a literature review on the medicoeconomic studies on the drug therapy of BPH.
METHOD
After analyzing the literature, 43 articles were found and 9 were selected for their relevance.
RESULTS
Based on Markov models, we observed that: combination therapy and combined treatments (alphablockers and inhibitors of 5-alpha reductase [5ARI]) seemed to have the best cost-effectiveness. Then came the alphablockers, less expensive but exposing to a greater risk of progression and to the necessity of surgical treatments. Then came the 5ARI monotherapy and finally simple monitoring.
CONCLUSION
The Markov models are imperfect tools, and resources invested in care depend on both the economic model and the value that individuals and society give to efficiency and cost.
Topics: Drug Therapy, Combination; Health Care Costs; Humans; Male; Prostatic Hyperplasia
PubMed: 26643518
DOI: 10.1016/j.purol.2015.10.010 -
La Revue de Medecine Interne Mar 2014Benign prostatic hyperplasia is a state of the nature rather than a disease. It affects mainly men over 50 years and represents a public health problem. A literature... (Review)
Review
Benign prostatic hyperplasia is a state of the nature rather than a disease. It affects mainly men over 50 years and represents a public health problem. A literature review on the therapeutic management of benign prostatic hyperplasia was carried out from a selection of publications with the highest level of evidence. Medical treatment is based on herbal medicine, alpha-blockers and 5-alpha-reductase inhibitors. Surgical treatment is used in case of complications or failure of medical management. Surgical options are numerous. Transurethral prostate resection and prostate adenomectomy are the most usual procedures. Due to their significant morbidity, other less invasive procedures have recently been developed. The choice of treatment will depend on prostate volume and anatomy and patient's comorbidities.
Topics: 5-alpha Reductase Inhibitors; Adenoma; Adrenergic alpha-1 Receptor Antagonists; Cholinergic Antagonists; Diagnosis, Differential; Humans; Male; Phytotherapy; Prostatic Hyperplasia; Prostatic Neoplasms; Urologic Surgical Procedures, Male; Urological Agents; Watchful Waiting
PubMed: 24262410
DOI: 10.1016/j.revmed.2013.10.007 -
The Journal of Laryngology and Otology May 1996A case of a benign histiocytoma of the larynx in a 39-year-old man is presented. Laryngeal fibrous histiocytoma is extremely rare. Its pathology is described including... (Review)
Review
A case of a benign histiocytoma of the larynx in a 39-year-old man is presented. Laryngeal fibrous histiocytoma is extremely rare. Its pathology is described including arguments for benignity. The literature is reviewed and management is discussed.
Topics: Adult; Histiocytoma, Benign Fibrous; Humans; Laryngeal Neoplasms; Male
PubMed: 8762322
DOI: 10.1017/s0022215100134024 -
Il Policlinico. Sezione Chirurgica 1953
Topics: Colon; Colonic Diseases; Duodenum; Fistula; Intestinal Fistula
PubMed: 13145335
DOI: No ID Found -
Der Radiologe Aug 2008Neuroendocrine tumors (NET) of the pancreas are rare neoplasms, which arise from cells of the islets of Langerhans. The most common NET are the insulinoma, gastrinoma... (Review)
Review
Neuroendocrine tumors (NET) of the pancreas are rare neoplasms, which arise from cells of the islets of Langerhans. The most common NET are the insulinoma, gastrinoma and hormone inactive NET. Very rare entities are the schwannoma, leiomyoma, teratoma, intrapancreatic lipoma, hemangioma and the intrapancreatic accessory spleen. Essential for therapy, which in most cases is difficult, are an exact localization and various modalities of imaging diagnostics.
Topics: Humans; Image Enhancement; Magnetic Resonance Imaging; Neuroendocrine Tumors; Pancreatic Neoplasms; Rare Diseases; Tomography, X-Ray Computed; Ultrasonography
PubMed: 18633589
DOI: 10.1007/s00117-008-1672-3 -
Annales de Pathologie Nov 2020HIV-related lymphoid hyperplasia has been exceptionally described outside lymph nodes. To our knowledge, 3 cases of nasopharyngeal localisation have been described in...
HIV-related lymphoid hyperplasia has been exceptionally described outside lymph nodes. To our knowledge, 3 cases of nasopharyngeal localisation have been described in the literature. We report here an intracranial localisation with an important ophthalmological clinical impact. Our observation allows us to approach the differential diagnoses of intracranial lesions in the HIV-positive patient, to analyse the differential diagnoses of benign lymphoid hyperplasia and to discuss the therapeutic options.
Topics: Diagnosis, Differential; HIV Infections; Humans; Hyperplasia; Pseudolymphoma
PubMed: 32718767
DOI: 10.1016/j.annpat.2020.06.001 -
Praxis 2017
Review
Topics: Embolization, Therapeutic; Humans; Kidney Calculi; Laparoscopy; Male; Prostate; Prostatectomy; Prostatic Neoplasms; Robotic Surgical Procedures; Ureteroscopy; Urinary Bladder Neck Obstruction; Urology
PubMed: 28537113
DOI: 10.1024/1661-8157/a002692